Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Handbook of Experimental Pharmacology|June 21, 2015
Gastrointestinal Safety Pharmacology in Drug Discovery and DevelopmentAhmad Al-Saffar, André Nogueira da Costa, Annie Delaunois, et al.
Journal of Pharmacological and Toxicological Methods|November 6, 2007
Optimisation and validation of a medium-throughput electrophysiology-based hNav1.5 assay using IonWorksA R Harmer, N Abi-Gerges, A Easter, et al.
Journal of Medicinal Chemistry|December 6, 1996
Serotonin dimers: application of the bivalent ligand approach to the design of new potent and selective 5-HT(1B/1D) agonistsS Halazy, M Perez, C Fourrier, et al.
British Journal of Pharmacology|May 1, 1995
Intrinsic activity of the non-prostanoid thromboxane A2 receptor antagonist, daltroban (BM 13,505), in human platelets in vitro and in the rat vasculature in vivoF Bertolino, J P Valentin, M Maffre, et al.
Journal of Pharmacological and Toxicological Methods|June 11, 2008
Validation of the use of zebrafish larvae in visual safety assessmentF M Richards, W K Alderton, G M Kimber, et al.
Toxicology and Applied Pharmacology|June 29, 2005
Biomarkers of drug-induced vascular injuryD Brott, S Gould, H Jones, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 9, 1998
F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potentialW Koek, J F Patoiseau, M B Assié, et al.
British Journal of Pharmacology|July 30, 2008
International Life Sciences Institute (Health and Environmental Sciences Institute, HESI) initiative on moving towards better predictors of drug-induced torsades de pointesA S Bass, B Darpo, A Breidenbach, et al.
Journal of Pharmacological and Toxicological Methods|January 14, 2018
An overview of the safety pharmacology society strategic planM K Pugsley, S Authier, J E Koerner, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 25, 1999
F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraineG W John, P J Pauwels, M Perez, et al.
Pageof 9